- Brouwer, Ingeborg;
- De Faire, Ulf;
- Eiriksdottir, Gudny;
- Ferrucci, Luigi;
- Forouhi, Nita;
- Geleijnse, Johanna;
- Hodge, Allison;
- Kimura, Hitomi;
- Laakso, Markku;
- Risérus, Ulf;
- van Westing, Anniek;
- Bandinelli, Stefania;
- Baylin, Ana;
- Giles, Graham;
- Gudnason, Vilmundur;
- Iso, Hiroyasu;
- Lemaitre, Rozenn;
- Ninomiya, Toshiharu;
- Post, Wendy;
- Psaty, Bruce;
- Salonen, Jukka;
- Schulze, Matthias;
- Tsai, Michael;
- Uusitupa, Matti;
- Wareham, Nicholas;
- Oh, Seung-Won;
- Wood, Alexis;
- Harris, William;
- Siscovick, David;
- Mozaffarian, Dariush;
- Leander, Karin;
- Laguzzi, Federica;
- Åkesson, Agneta;
- Marklund, Matti;
- Qian, Frank;
- Gigante, Bruna;
- Bartz, Traci;
- Bassett, Julie;
- Birukov, Anna;
- Campos, Hannia;
- Hirakawa, Yoichiro;
- Imamura, Fumiaki;
- Jäger, Susanne;
- Lankinen, Maria;
- Murphy, Rachel;
- Senn, Mackenzie;
- Tanaka, Toshiko;
- Tintle, Nathan;
- Virtanen, Jyrki;
- Yamagishi, Kazumasa;
- Allison, Matthew
BACKGROUND: It is unknown whether dietary intake of polyunsaturated fatty acids (PUFA) modifies the cardiovascular disease (CVD) risk associated with a family history of CVD. We assessed interactions between biomarkers of low PUFA intake and a family history in relation to long-term CVD risk in a large consortium. METHODS: Blood and tissue PUFA data from 40 885 CVD-free adults were assessed. PUFA levels ≤25th percentile were considered to reflect low intake of linoleic, alpha-linolenic, and eicosapentaenoic/docosahexaenoic acids (EPA/DHA). Family history was defined as having ≥1 first-degree relative who experienced a CVD event. Relative risks with 95% CI of CVD were estimated using Cox regression and meta-analyzed. Interactions were assessed by analyzing product terms and calculating relative excess risk due to interaction. RESULTS: After multivariable adjustments, a significant interaction between low EPA/DHA and family history was observed (product term pooled RR, 1.09 [95% CI, 1.02-1.16]; P=0.01). The pooled relative risk of CVD associated with the combined exposure to low EPA/DHA, and family history was 1.41 (95% CI, 1.30-1.54), whereas it was 1.25 (95% CI, 1.16-1.33) for family history alone and 1.06 (95% CI, 0.98-1.14) for EPA/DHA alone, compared with those with neither exposure. The relative excess risk due to interaction results indicated no interactions. CONCLUSIONS: A significant interaction between biomarkers of low EPA/DHA intake, but not the other PUFA, and a family history was observed. This novel finding might suggest a need to emphasize the benefit of consuming oily fish for individuals with a family history of CVD.